FREE Case Review (866) 588-0600

Invokana Linked to Heart Attack Risk in Clinical Trials

Results of post-marketing studies performed on Invokana identified a significantly increased risk of heart attack in patients who took the medication during their first 30 days of treatment.

Results of post-marketing studies performed on the type 2 diabetes drug Invokana (generic: canagliflozin) identified a significantly increased risk of heart attack in patients who took the medication during their first 30 days of treatment.

Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Invokana side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the Problem?

During the trials, several Invokana users suddenly developed heart attacks or strokes within the first 30 days of treatment. After the 30-day period passed, the risk factors suddenly and inexplicably leveled out. The study’s authors were unable to determine exactly why this occurred, although it is well understood that diabetes medications can increase patients’ cholesterol levels, which can lead to heart problems.

Despite the fact that the U.S. Food & Drug Administration (FDA) recently issued a public safety warning regarding Invokana, and has required manufacturer Janssen Pharmaceuticals to update the medicine’s warning label, the agency has made no mention of the heart attack risk associated with the drug.

According to The New York Times, “The label of the drug includes no warnings about heart attacks or strokes. …The FDA is requiring Johnson & Johnson to conduct five post-marketing studies, including a clinical trial to determine more definitively if the drug increases those risks.”

While the complete results from these trials have yet to be published, medical professionals are asking that all patients taking Invokana or other SGLT2 inhibitor diabetes drugs watch for symptoms of an impending heart attack, which may include:

  • Arm, jaw, neck, chest and shoulder pain
  • Dizziness
  • Nausea / vomiting
  • Fatigue
  • Sweating
  • Difficulty breathing

Invokana users are asked to remain extra cautious while looking for symptoms during the first 30 days of treatment, due to the study results which highlighted this as a particularly high-risk time. Patients experiencing any of these symptoms should contact their doctor immediately.

Do I Have an Invokana Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently investigating potential settlements in all 50 states.

Free Confidential Case Evaluation: Again, if you suffered a heart attack or other serious side effect from Invokana,you should contact our law firm immediately. You may be entitled to a settlement by filing a lawsuit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition